IG 271 1.25mg Pill - yellow capsule/oblong, 4mm
Pill with imprint IG 271 1.25mg is Yellow, Capsule/Oblong and has been identified as Ramipril 1.25 mg. It is supplied by InvaGen Pharmaceuticals, Inc.
Ramipril is used in the treatment of High Blood Pressure; Left Ventricular Dysfunction; Diabetic Kidney Disease; Heart Failure; Cardiovascular Risk Reduction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 271 1.25mg
Ramipril
- Imprint
- IG 271 1.25mg
- Strength
- 1.25 mg
- Color
- Yellow
- Size
- 4.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- InvaGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 67787-0271
More about ramipril
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (128)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Angiotensin Converting Enzyme Inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
